Nancy Sohler to Buprenorphine
This is a "connection" page, showing publications Nancy Sohler has written about Buprenorphine.
Connection Strength
3.873
-
Cunningham CO, Roose RJ, Starrels JL, Giovanniello A, Sohler NL. Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes. J Addict Med. 2013 Jul-Aug; 7(4):287-93.
Score: 0.392
-
Cunningham CO, Giovanniello A, Kunins HV, Roose RJ, Fox AD, Sohler NL. Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users. Am J Addict. 2013 Jul-Aug; 22(4):352-7.
Score: 0.392
-
Sohler NL, Weiss L, Egan JE, L?pez CM, Favaro J, Cordero R, Cunningham CO. Consumer attitudes about opioid addiction treatment: a focus group study in New York City. J Opioid Manag. 2013 Mar-Apr; 9(2):111-9.
Score: 0.383
-
Cunningham CO, Giovanniello A, Li X, Kunins HV, Roose RJ, Sohler NL. A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions. J Subst Abuse Treat. 2011 Jun; 40(4):349-56.
Score: 0.333
-
Sohler NL, Li X, Kunins HV, Sacajiu G, Giovanniello A, Whitley S, Cunningham CO. Home- versus office-based buprenorphine inductions for opioid-dependent patients. J Subst Abuse Treat. 2010 Mar; 38(2):153-9.
Score: 0.302
-
Cunningham CO, Giovanniello A, Sacajiu G, Li X, Brisbane M, Sohler NL. Inquiries about and initiation of buprenorphine treatment in an inner-city clinic. Subst Abus. 2009 Jul-Sep; 30(3):261-2.
Score: 0.297
-
Cunningham C, Giovanniello A, Sacajiu G, Whitley S, Mund P, Beil R, Sohler N. Buprenorphine treatment in an urban community health center: what to expect. Fam Med. 2008 Jul-Aug; 40(7):500-6.
Score: 0.277
-
Cunningham CO, Kunins HV, Roose RJ, Elam RT, Sohler NL. Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians. J Gen Intern Med. 2007 Sep; 22(9):1325-9.
Score: 0.259
-
Fox AD, Sohler NL, Frost T, Lopez C, Cunningham CO. Development and evaluation of a community-based buprenorphine treatment intervention. Harm Reduct J. 2017 05 12; 14(1):23.
Score: 0.128
-
Fox AD, Chamberlain A, Sohler NL, Frost T, Cunningham CO. Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants. J Subst Abuse Treat. 2015 Jan; 48(1):112-6.
Score: 0.106
-
Nahvi S, Blackstock O, Sohler NL, Thompson D, Cunningham CO. Smoking cessation treatment among office-based buprenorphine treatment patients. J Subst Abuse Treat. 2014 Aug; 47(2):175-9.
Score: 0.104
-
Fox AD, Shah PA, Sohler NL, Lopez CM, Starrels JL, Cunningham CO. I heard about it from a friend: assessing interest in buprenorphine treatment. Subst Abus. 2014; 35(1):74-9.
Score: 0.101
-
Shah PA, Sohler NL, L?pez C, Fox AD, Cunningham CO. Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program. J Opioid Manag. 2013 Nov-Dec; 9(6):407-13.
Score: 0.100
-
Kunins HV, Sohler NL, Giovanniello A, Thompson D, Cunningham CO. A buprenorphine education and training program for primary care residents: implementation and evaluation. Subst Abus. 2013; 34(3):242-7.
Score: 0.095
-
Fox AD, Sohler NL, Starrels JL, Ning Y, Giovanniello A, Cunningham CO. Pain is not associated with worse office-based buprenorphine treatment outcomes. Subst Abus. 2012; 33(4):361-5.
Score: 0.088
-
Schackman BR, Leff JA, Botsko M, Fiellin DA, Altice FL, Korthuis PT, Sohler N, Weiss L, Egan JE, Netherland J, Gass J, Finkelstein R. The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation. J Acquir Immune Defic Syndr. 2011 Mar 01; 56 Suppl 1:S76-82.
Score: 0.083
-
Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. J Acquir Immune Defic Syndr. 2011 Mar 01; 56 Suppl 1:S83-90.
Score: 0.083
-
Whitley SD, Sohler NL, Kunins HV, Giovanniello A, Li X, Sacajiu G, Cunningham CO. Factors associated with complicated buprenorphine inductions. J Subst Abuse Treat. 2010 Jul; 39(1):51-7.
Score: 0.080
-
Kunins HV, Sohler NL, Roose RJ, Cunningham CO. HIV provider endorsement of primary care buprenorphine treatment: a vignette study. Fam Med. 2009 Nov-Dec; 41(10):722-8.
Score: 0.076
-
Netherland J, Botsko M, Egan JE, Saxon AJ, Cunningham CO, Finkelstein R, Gourevitch MN, Renner JA, Sohler N, Sullivan LE, Weiss L, Fiellin DA. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009 Apr; 36(3):244-51.
Score: 0.070
-
Roose RJ, Kunins HV, Sohler NL, Elam RT, Cunningham CO. Nurse practitioner and physician assistant interest in prescribing buprenorphine. J Subst Abuse Treat. 2008 Jun; 34(4):456-9.
Score: 0.065
-
Cunningham CO, Sohler NL, McCoy K, Kunins HV. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital. Fam Med. 2006 May; 38(5):336-40.
Score: 0.060